Atmosphere-ph.ru

Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru

ИНТЕРНЕТ-МАГАЗИН

Телефон издательства

Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2018 / N 1

Саркоидоз: что мы знаем и что мы можем
А.А. Визель, И.Ю. Визель

Список литературы
1. Dubrey S, Shah S, Hardman T, Sharma R. Sarcoidosis: the links between epidemiology and aetiology. Postgraduate Medical Journal 2014 Oct;90(1068):582-9.
2. Baughman RP, Lower EE. Treatment of sarcoidosis. Clinical Reviews in Allergy & Immunology 2015 Aug;49(1):79-92.
3. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. American Journal of Respiratory and Critical Care Medicine 1999 Aug;160(2):736-55.
4. Amber KT, Bloom R, Mrowietz U, Hertl M. TNF-α: a treatment target or cause of sarcoidosis? Journal of the European Academy of Dermatology and Venereology 2015 Nov;29(11):2104-11.
5. Özdemir L, Özdemir B. A prospective review of the results of patients treated and followed up for a diagnosis of sarcoidosis. Turkish Thoracic Journal 2018 Jan;19(1):1-6.
6. West SG. Current management of sarcoidosis I: pulmonary, cardiac, and neurologic manifestations. Current Opinion in Rheumatology 2018 Jan; doi: 10.1097/BOR.0000000000000489. [Epub ahead of print]
7. Boucly A, Cottin V, Nunes H, Jaïs X, Tazi A, Prévôt G, Reynaud-Gaubert M, Dromer C, Viacroze C, Horeau-Langlard D, Pison C, Bergot E, Traclet J, Weatherald J, Simonneau G, Valeyre D, Montani D, Humbert M, Sitbon O, Savale L. Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension. The European Respiratory Journal 2017 Oct;50(4). pii: 1700465. doi: 10.1183/13993003.00465-2017. Print 2017 Oct.
8. Strookappe B, Elfferich M, Swigris J, Verschoof A, Veschakelen J, Knevel T, Drent M. Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study. Sarcoidosis, Vasculitis and Diffuse Lung Diseases 2015 Jan;32(1):43-52.
9. Hendriks C, Drent M, De Kleijn W, Elfferich M, Wijnen P, De Vries J. Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: a prospective follow-up study. Respiratory Medicine 2017 Nov; pii: S0954-6111(17)30382-7.
10. Brown F, Tanner LS. Lofgren syndrome. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2018 Jan. Last update 2018 Feb 8.
11. Bhalla AS, Das A, Naranje P, Goyal A, Guleria R, Khilnani GC. Dilemma of diagnosing thoracic sarcoidosis in tuberculosis endemic regions: an imaging-based approach. Part 1. Indian Journal of Radiology and Imaging 2017 Oct-Dec;27(4):369-79.
12. Oskuei A, Hicks L, Ghaffar H, Hoffstein V. Sarcoidosis-lymphoma syndrome: a diagnostic dilemma. BMJ Case Reports 2017 Dec: pii: bcr-2017-220065. doi: 10.1136/bcr-2017-220065.
13. Springer-Wanner C, Brauns T. Ocular sarcoidosis. Zeitschrift für Rheumatologie 2017 Jun;76(5):391-7.
14. Elikowski W, Małek-Elikowska M, Świerkocki K, Wróblewski D, Bolewski A, Janus M. Utility of left ventricular longitudinal strain in the diagnosis and treatment monitoring of cardiac sarcoidosis. Polish Archives of Internal Medicine 2018 Feb;128(2):126-8.
15. Maskery MP, Cooper PN, Pace A. Neurosarcoidosis associated with intracerebral haemorrhage: a challenge in diagnosis and management. Practical Neurology 2018. pii: practneurol-2017-001794. doi: 10.1136/practneurol-2017-001794. [Epub ahead of print].
16. Kieszko R, Krawczyk P, Michnar M, Chocholska S, Milanowski J. The yield of endobronchial biopsy in pulmonary sarcoidosis: connection between spirometric impairment and lymphocyte subpopulations in bronchoalveolar lavage fluid. Respiration 2004 Jan-Feb;71(1):72-6.
17. Valeyre D, Bernaudin JF, Jeny F, Duchemann B, Freynet O, Planès C, Kambouchner M, Nunes H. Pulmonary sarcoidosis. Clinics In Chest Medicine 2015 Dec;36(4):631-41.
18. Чучалин А.Г., Визель А.А., Илькович М.М., Авдеев С.Н., Амиров Н.Б., Баранова О.П., Борисов С. Е., Визель И.Ю., Ловачева О.В., Овсянников Н.В., Петров Д.В., Романов В.В., Самсонова М.В., Соловьева И.П., Соловьева И.П., Степанян И.Э., Тюрин И.Е., Черняев А.Л., Шмелев Е.И., Шмелева Н.М. Диагностика и лечение саркоидоза: резюме федеральных согласительных клинических рекомендаций. Часть 1: Классификация, этиопатогенез, клиника. Вестник современной клинической медицины 2014;7(4):62-70.
19. Broos CE, Wapenaar M, Looman CWN, In 't Veen JCCM3 van den Toorn LM, Overbeek MJ, Grootenboers MJJH, Heller R, Mostard RL, Poell LHC, Hoogsteden HC, Kool M, Wijsenbeek MS, van den Blink B. Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis. The European Respiratory Journal 2018 Jan;51(1). pii: 1702089. doi: 10.1183/13993003.02089-2017. Print 2018 Jan.
20. Чучалин А.Г., Айсанов З.Р., Чикина С.Ю., Черняк А.В., Калманова Е.Н. Федеральные клинические рекомендации Российского респираторного общества по использованию метода спирометрии. Пульмонология 2014;6:11-23.
21. Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Minimal clinically important differences in pharmacological trials. American Journal of Respiratory and Critical Care Medicine 2014 Feb;189(3):250-5.
22. Чучалин А.Г., Авдеев С.Н., Айсанов З.Р., Белевский А.С., Демура С.А., Илькович М.М., Коган Е.А., Самсонова М.В., Сперанская А.А., Тюрин И.Е., Черняев А.Л., Черняк Б.А., Черник А.В., Шмелев Е.И. Идиопатический легочный фиброз. Клинические рекомендации. Российское Респираторное общество; 2016. 44 с. Доступно по: www.spulmo.ru Ссылка активна на 31.05.2018.
23. Визель И.Ю. Саркоидоз в Республике Татарстан: эффективность диагностики и лечения, анализ отдаленных результатов: Автореф. дис. … докт. мед. наук. Москва, 2017. 48 с.
24. Broos CE, Poell LHC, Looman CWN, In 't Veen JCCM, Grootenboers MJJH, Heller R6, van den Toorn LM, Wapenaar M, Hoogsteden HC, Kool M, Wijsenbeek MS, van den Blink B. No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis. Respiratory Medicine 2017 Oct; pii: S0954-6111(17)30361-X. doi: 10.1016/j.rmed.2017.10.022. [Epub ahead of print].
25. Jones NP, Tsierkezou L, Patton N. Lymphopenia as a predictor of sarcoidosis in patients with uveitis. British Journal of Ophthalmology 2016 Jan; pii: bjophthalmol-2015-307455. doi: 10.1136/bjophthalmol-2015-307455. Epub 2016 Jan 4.
26. Бекетов В.Д., Лебедева М.В., Мухин Н.А., Попова Е.Н., Серова А.Г., Соломка В.А., Кондрашов А.В., Пономарев А.Б., Бровко М.Ю. Клиническое значение определения сурфактантных протеинов A и D в оценке активности саркоидоза. Фарматека 2017;14(347):52-6.
27. Schupp JC, Freitag-Wolf S, Bargagli E. Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O’Reilly K, Ho LP, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane MP, O’Beirne S, Donnelly S, Haraldsdottir SO, Jorundsdottir KB, Costabel U, Bonella F, Wallaert B, Grah C, Peroš-Golubičić T, Luisetti M, Kadija Z, Pabst S, Grohé C, Strausz J, Vašáková M, Sterclova M, Millar A, Homolka J, Slováková A, Kendrick Y, Crawshaw A, Wuyts W, Spencer L, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Krawczak M, Müller-Quernheim J. Phenotypes of organ involvement in sarcoidosis. The European Respiratory Journal 2018 Jan;51(1): pii: 1700991. doi: 10.1183/13993003.00991-2017. Print 2018 Jan.
28. Pereira CA, Dornfeld MC, Baughman R, Judson MA. Clinical phenotypes in sarcoidosis. Current Opinion in Pulmonary Medicine 2014 Sep;20(5):496-502.
29. Culver DA, Baughman RP. It’s time to evolve from Scadding: phenotyping sarcoidosis. The European Respiratory Journal 2018 Jan;51(1 ). pii: 1800050. doi: 10.1183/13993003.00050-2018. Print 2018 Jan.
30. Федеральные клинические рекомендации по диагностике и лечению саркоидоза. Российское респираторное общество. 2016. Доступно по: www.spulmo.ru Ссылка активна на 31.05.2018.

References
1. Dubrey S, Shah S, Hardman T, Sharma R. Sarcoidosis: the links between epidemiology and aetiology. Postgraduate Medical Journal 2014 Oct;90(1068):582-9.
2. Baughman RP, Lower EE. Treatment of sarcoidosis. Clinical Reviews in Allergy & Immunology 2015 Aug;49(1):79-92.
3. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. American Journal of Respiratory and Critical Care Medicine 1999 Aug;160(2):736-55.
4. Amber KT, Bloom R, Mrowietz U, Hertl M. TNF-α: a treatment target or cause of sarcoidosis? Journal of the European Academy of Dermatology and Venereology 2015 Nov;29(11):2104-11.
5. Özdemir L, Özdemir B. A prospective review of the results of patients treated and followed up for a diagnosis of sarcoidosis. Turkish Thoracic Journal 2018 Jan;19(1):1-6.
6. West SG. Current management of sarcoidosis I: pulmonary, cardiac, and neurologic manifestations. Current Opinion in Rheumatology 2018 Jan; doi: 10.1097/BOR.0000000000000489. [Epub ahead of print]
7. Boucly A, Cottin V, Nunes H, Jaïs X, Tazi A, Prévôt G, Reynaud-Gaubert M, Dromer C, Viacroze C, Horeau-Langlard D, Pison C, Bergot E, Traclet J, Weatherald J, Simonneau G, Valeyre D, Montani D, Humbert M, Sitbon O, Savale L. Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension. The European Respiratory Journal 2017 Oct;50(4). pii: 1700465. doi: 10.1183/13993003.00465-2017. Print 2017 Oct.
8. Strookappe B, Elfferich M, Swigris J, Verschoof A, Veschakelen J, Knevel T, Drent M. Benefits of physical training in patients with idiopathic or end-stage sarcoidosis-related pulmonary fibrosis: a pilot study. Sarcoidosis, Vasculitis and Diffuse Lung Diseases 2015 Jan;32(1):43-52.
9. Hendriks C, Drent M, De Kleijn W, Elfferich M, Wijnen P, De Vries J. Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: a prospective follow-up study. Respiratory Medicine 2017 Nov; pii: S0954-6111(17)30382-7.
10. Brown F, Tanner LS. Lofgren syndrome. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2018 Jan. Last update 2018 Feb 8.
11. Bhalla AS, Das A, Naranje P, Goyal A, Guleria R, Khilnani GC. Dilemma of diagnosing thoracic sarcoidosis in tuberculosis endemic regions: an imaging-based approach. Part 1. Indian Journal of Radiology and Imaging 2017 Oct-Dec;27(4):369-79.
12. Oskuei A, Hicks L, Ghaffar H, Hoffstein V. Sarcoidosis-lymphoma syndrome: a diagnostic dilemma. BMJ Case Reports 2017 Dec: pii: bcr-2017-220065. doi: 10.1136/bcr-2017-220065.
13. Springer-Wanner C, Brauns T. Ocular sarcoidosis. Zeitschrift für Rheumatologie 2017 Jun;76(5):391-7.
14. Elikowski W, Małek-Elikowska M, Świerkocki K, Wróblewski D, Bolewski A, Janus M. Utility of left ventricular longitudinal strain in the diagnosis and treatment monitoring of cardiac sarcoidosis. Polish Archives of Internal Medicine 2018 Feb;128(2):126-8.
15. Maskery MP, Cooper PN, Pace A. Neurosarcoidosis associated with intracerebral haemorrhage: a challenge in diagnosis and management. Practical Neurology 2018. pii: practneurol-2017-001794. doi: 10.1136/practneurol-2017-001794. [Epub ahead of print].
16. Kieszko R, Krawczyk P, Michnar M, Chocholska S, Milanowski J. The yield of endobronchial biopsy in pulmonary sarcoidosis: connection between spirometric impairment and lymphocyte subpopulations in bronchoalveolar lavage fluid. Respiration 2004 Jan-Feb;71(1):72-6.
17. Valeyre D, Bernaudin JF, Jeny F, Duchemann B, Freynet O, Planès C, Kambouchner M, Nunes H. Pulmonary sarcoidosis. Clinics In Chest Medicine 2015 Dec;36(4):631-41.
18. Chuchalin AG, Vizel AA, Ilkovich MM, Avdeev SN, Amirov NB, Baranova OP, Borisov SE, Vizel IYu, Lovacheva OV, Ovsyannikov NV, Petrov DV, Romanov VV, Samsonovа MV, Solovyova IP, Stepanian IE, Tyurin IE, Cherniayev AL, Shmelev EI, Shmeleva NM. Diagnosis and treatment of sarcoidosis. Summary of federal conciliative clinical recommendations. Part I. Classification, etiopathogenesis, clinic. The Bulletin of Contemporary Clinical Medicine 2014;7(4):62-70 (In Russian).
19. Broos CE, Wapenaar M, Looman CWN, In 't Veen JCCM3 van den Toorn LM, Overbeek MJ, Grootenboers MJJH, Heller R, Mostard RL, Poell LHC, Hoogsteden HC, Kool M, Wijsenbeek MS, van den Blink B. Daily home spirometry to detect early steroid treatment effects in newly treated pulmonary sarcoidosis. The European Respiratory Journal 2018 Jan;51(1). pii: 1702089. doi: 10.1183/13993003.02089-2017. Print 2018 Jan.
20. Chuchalin AG, Aysanov ZR, Chikina SYu, Chernyak AV, Kalmanova EN. Federal guidelines of Russian Respiratory Society on spirometry. Russian Pulmonology 2014;6:11-23 (In Russian).
21. Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Minimal clinically important differences in pharmacological trials. American Journal of Respiratory and Critical Care Medicine 2014 Feb;189(3):250-5.
22. Chuchalin AG, Avdeev SN, Aysanov ZR, Belevskiy AS., Demura SA, Ilkovich MM, Kogan EA, Samsonova MV, Speranskaya AA, Tyurin IE, Chernyaev AL, Chernyak BA, Chernik VA, Shmelev EI. Idiopathic pulmonary fibrosis. Clinical guidelines. Russian Respiratory Society; 2016. 44 p. (In Russian). Available from: www.spulmo.ru Accessed 2018 May 31.
23. Visel IYu. Sarcoidosis in the Republic of Tatarstan: diagnosis and treatment efficiency, analysis of long-term results [abstract of dissertation for the degree of Doctor of Medical Sciences]. Moscow; 2017. 48 p. (In Russian).
24. Broos CE, Poell LHC, Looman CWN, In 't Veen JCCM, Grootenboers MJJH, Heller R6, van den Toorn LM, Wapenaar M, Hoogsteden HC, Kool M, Wijsenbeek MS, van den Blink B. No evidence found for an association between prednisone dose and FVC change in newly-treated pulmonary sarcoidosis. Respiratory Medicine 2017 Oct; pii: S0954-6111(17)30361-X. doi: 10.1016/j.rmed.2017.10.022. [Epub ahead of print].
25. Jones NP, Tsierkezou L, Patton N. Lymphopenia as a predictor of sarcoidosis in patients with uveitis. British Journal of Ophthalmology 2016 Jan; pii: bjophthalmol-2015-307455. doi: 10.1136/bjophthalmol-2015-307455. Epub 2016 Jan 4.
26. Beketov VD, Lebedeva MV, Mukhin NA, Popova EN, Serova AG, Solomka VA, Kondrashov AV, Ponomarev AB, Brovko MYu. Clinical relevance of the determination of surfactant protein A and D in assessment of sarcoidosis activity. Pharmateca 2017;14(347):52-6 (In Russian).
27. Schupp JC, Freitag-Wolf S, Bargagli E. Mihailović-Vučinić V, Rottoli P, Grubanovic A, Müller A, Jochens A, Tittmann L, Schnerch J, Olivieri C, Fischer A, Jovanovic D, Filipovic S, Videnovic-Ivanovic J, Bresser P, Jonkers R, O’Reilly K, Ho LP, Gaede KI, Zabel P, Dubaniewicz A, Marshall B, Kieszko R, Milanowski J, Günther A, Weihrich A, Petrek M, Kolek V, Keane MP, O’Beirne S, Donnelly S, Haraldsdottir SO, Jorundsdottir KB, Costabel U, Bonella F, Wallaert B, Grah C, Peroš-Golubičić T, Luisetti M, Kadija Z, Pabst S, Grohé C, Strausz J, Vašáková M, Sterclova M, Millar A, Homolka J, Slováková A, Kendrick Y, Crawshaw A, Wuyts W, Spencer L, Pfeifer M, Valeyre D, Poletti V, Wirtz H, Prasse A, Schreiber S, Krawczak M, Müller-Quernheim J. Phenotypes of organ involvement in sarcoidosis. The European Respiratory Journal 2018 Jan;51(1): pii: 1700991. doi: 10.1183/13993003.00991-2017. Print 2018 Jan.
28. Pereira CA, Dornfeld MC, Baughman R, Judson MA. Clinical phenotypes in sarcoidosis. Current Opinion in Pulmonary Medicine 2014 Sep;20(5):496-502.
29. Culver DA, Baughman RP. It’s time to evolve from Scadding: phenotyping sarcoidosis. The European Respiratory Journal 2018 Jan;51(1 ). pii: 1800050. doi: 10.1183/13993003.00050-2018. Print 2018 Jan.
30. Russian federal clinical guidelines for the diagnosis and treatment of sarcoidosis. Russian Respiratory Society, 2016. (In Russian). Available from: www.spulmo.ru Accessed 2018 May 31.

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]